HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

B E Johnson Selected Research

Small Cell Lung Carcinoma (Small Cell Lung Cancer)

2/2014A phase Ib dose-escalation study of everolimus combined with cisplatin and etoposide as first-line therapy in patients with extensive-stage small-cell lung cancer.
8/2004Phase II study of the farnesyl transferase inhibitor R115777 in patients with sensitive relapse small-cell lung cancer.
2/2001Is more better? Chemotherapy for patients with extensive-stage small-cell lung cancer.
10/2000A model to select chemotherapy regimens for phase III trials for extensive-stage small-cell lung cancer.
9/2000Loss-of-heterozygosity analysis of small-cell lung carcinomas using single-nucleotide polymorphism arrays.
7/2000Growth inhibition and modulation of kinase pathways of small cell lung cancer cell lines by the novel tyrosine kinase inhibitor STI 571.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


B E Johnson Research Topics

Disease

10Neoplasms (Cancer)
01/2022 - 03/2000
6Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
10/2014 - 07/2000
6Small Cell Lung Carcinoma (Small Cell Lung Cancer)
02/2014 - 07/2000
3Lung Neoplasms (Lung Cancer)
12/2001 - 10/2000
1COVID-19
01/2022
1Infections
01/2022
1Stomatitis
02/2014
1Adenocarcinoma
11/2001
1Carcinoma (Carcinomatosis)
11/2001
1Dyspnea (Shortness of Breath)
01/2001
1Disease Progression
07/2000
1Brain Neoplasms (Brain Tumor)
07/2000

Drug/Important Bio-Agent (IBA)

2Cisplatin (Platino)FDA LinkGeneric
02/2014 - 07/2000
2EverolimusFDA Link
02/2014 - 02/2014
2Paclitaxel (Taxol)FDA LinkGeneric
12/2001 - 07/2000
2DNA (Deoxyribonucleic Acid)IBA
09/2000 - 03/2000
1ErbB Receptors (EGF Receptor)IBA
10/2014
1vandetanib (ZD6474)IBA
10/2014
1Docetaxel (Taxotere)FDA Link
10/2014
1Proteins (Proteins, Gene)FDA Link
10/2014
1Biomarkers (Surrogate Marker)IBA
10/2014
1TOR Serine-Threonine KinasesIBA
02/2014
1Erlotinib Hydrochloride (CP 358,774)FDA Link
02/2014
1Etoposide (VP 16)FDA LinkGeneric
02/2014
1tipifarnib (R115777)IBA
08/2004
1TransferasesIBA
08/2004
1OligonucleotidesIBA
11/2001
1Messenger RNA (mRNA)IBA
11/2001
1Oxygen (Dioxygen)IBA
01/2001
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
10/2000
1Genetic Markers (Genetic Marker)IBA
09/2000
1Tyrosine Kinase InhibitorsIBA
07/2000
1Stem Cell FactorIBA
07/2000
1Imatinib Mesylate (Gleevec)FDA Link
07/2000
1Phosphotransferases (Kinase)IBA
07/2000

Therapy/Procedure

7Therapeutics
01/2022 - 07/2000
3Drug Therapy (Chemotherapy)
02/2001 - 10/2000
1Cranial Irradiation
07/2000